Bookedited by Paula B. Andrade, Patrícia Valentão, David M. Pereira.
Summary: The past decade has seen the reappearance of natural products as a valuable source of potent therapeutics. Here, experts on bioactive natural products cover the full spectrum of clinically relevant enzymes that are known to be targeted by natural products. Key enzymes include acetylcholine esterase, angiotensin-I-converting enzyme, cyclooxygenase, dihydrofolate reductase, phospholipase A2, respiratory complexes, and many more. By connecting the diversity of medicinal natural product sources with their potential clinical applications, this volume serves as a companion for the medicinal chemist looking for innovative small molecule compounds as well as for pharmacologist interested in the clinical effects and mode of action of herbal and traditional medicines.
Contents:
Natural products as enzyme inhibitors
Molecular targets of clinically relevant natural products from filamentous marine cyanobacteria
Natural angiotensin converting enzyme (ACE) inhibitors with antihypertensive properties
Phospholipase A2 inhibitors of marine origin
Beta-secretase (BACE1) inhibitors from natural products
Hypoglycaemic effects of plants food constituents via inhibition of carbohydrate-hydrolysing enzymes: from chemistry to future applications
Natural products targeting clinically relevant enzymes of eicosanoid biosynthesis implicated in inflammation and cancer
Anti-HIV natural products
Natural inhibitors of mitochondrial respiratory chain: therapeutic and toxicological implications
Targeting enzymatic pathways with marine-derived clinical agents
Anti-malarial drug discovery: new enzyme inhibitors
Natural plant-derived acetylcholinesterase inhibitors: relevance for Alzheimer's disease.